Delivery Order SPE2DR25D3008-SPE2DR26F3P4F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,790.08 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 7, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $44,026.89 firm fixed-price delivery order to Amerisourcebergen Drug Corp (Cencora, Inc.) on January 7, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of January 8, 2026, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $35,911.43. This firm fixed-price, competitively awarded delivery order is set to be completed by January 8, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical supply needs, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $7,057.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with a completion deadline of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract valued at $5,685.12. The award was made on January 2, 2026, with an ultimate completion date of January 5, 2026, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,290.46 to Amerisourcebergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under Amerisourcebergen's parent organization, Cencora, Inc., which operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $82,443.45 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 7, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $27,773.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Arimidex 1 mg, with an ultimate completion date of January 12, 2026. This competitively awarded, non-set-aside contract was issued on January 9, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a $13,575.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on January 12, 2026, with completion targeted for January 13, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $5,685.12 delivery order to AmerSourceBergen Drug Corp on January 8, 2026, for the supply of Arimidex 1 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of January 9, 2026, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to...
- SPE2DR25D3008Indefinite Delivery Contract
- SPE2DR25D3008-SPE2DR26F3P4FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35.85K to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 12, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This is a firm fixed-price contract with an ultimate completion date of January 13, 2026, and represents a non-set-aside award issued through competitive procurement. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical and medical supply mechanism supporting military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The DLA Troop Support Medical utilizes this IDC structure to efficiently procure essential pharmaceutical products for Defense Health Agency operations, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 1/11/26 |